Key result
Aspirin deprescribing intervention linked to sustained reduction in use among warfarin patients with VTE or AFib.
Why the study?
It was unknown whether an aspirin deprescription intervention is associated with a sustained decrease in aspirin use among patients receiving warfarin for venous thromboembolism and/or atrial fibrillation.
Population
Patients receiving warfarin for venous thromboembolism and/or atrial fibrillation
Comparison
Aspirin deprescription intervention
Design
Multicenter quality improvement study
Supports cautious aspirin deprescription in select warfarin patients; leaves open whether outcomes improve without RCTs.
This quality improvement study examines whether an aspirin deprescription intervention is associated with a sustained decrease in aspirin use among patients receiving warfarin for venous thromboembolism and/or atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Sinha et al. (2026) studied this question. A multicenter aspirin deprescribing intervention was evaluated for its association with a sustained decrease in aspirin use among patients receiving warfarin for VTE or atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: